State Audit Office Flags Underutilization of Nuclear Medicine Facility

The recent audit by the Supreme Audit Office (NKÚ) has cast a stark light on the underutilization of Slovakia's BIONT nuclear medicine facility, a situation that demands immediate attention from our government.

It is deeply concerning that a state-of-the-art facility, capable of top-tier diagnostics for critical conditions like cancer and neurological disorders, is not being fully leveraged. The NKÚ's findings reveal that health insurance providers have limited contracts with BIONT, preventing the facility from operating at its full potential. This is not just an administrative oversight; it's a failure to provide our citizens with the best possible healthcare.

“

The state, according to the Supreme Audit Office (NKÚ) of the Slovak Republic, is not sufficiently utilizing the capacities of the BIONT nuclear medicine facility in Bratislava.

The audit also points to a complex financial entanglement, where a contract with a private company, Dr. Magnet, has indirectly benefited BIONT, while direct contracts with health insurers would have yielded millions more for the state company. This raises questions about the efficiency and transparency of our public healthcare procurement and financial management.

“

The state company concluded a contract in 2011 with the private company Dr. Magnet, which also has contracts with health insurance companies for similar services. The contract with the private company thus ultimately had a positive impact on BIONT's economy in the controlled years 2022 to 2024, but in the case of contracts concluded directly with health insurance companies, the state company's revenue would have been approximately three million euros higher.

The NKÚ's recommendation to transfer BIONT's ownership to the Ministry of Health is a sensible step. Health policy should be driven by health needs, not by the administrative purview of the Ministry of Education. This shift could streamline operations and ensure that BIONT's resources are aligned with national health priorities, ultimately benefiting the Slovak people.

Slovaks deserve access to the most advanced medical technologies available. We must ensure that our state-owned enterprises are managed effectively and that their capacities are fully utilized for the public good. This situation at BIONT is a clear call to action for improved governance and strategic investment in our healthcare infrastructure.

“

The state company has been dealing with the problem of financial limits set by health insurance companies below the capacities of its top-class facility and the real demand for expert examinations since the beginning of its existence.